Vitalis Foundation

Research

Vitalis Foundation conducts its own research into long COVID. Our research is led by our Research Director, Dr Abdul Mannan Baig.

Current projects

In progress

Spike protein research

Studying the SARS-CoV-2 spike protein and its role in long COVID.

Team
Sandy Rosko, Research Associate

In progress

Drug repurposing for long COVID

Identifying existing, approved medicines that could be repurposed to treat long COVID.

Team
Sandy Rosko, Research Associate

Research team

Publications by our researchers

Vitalis Foundation was founded in 2025, and its current projects are still in progress. Before then, our researchers published widely on COVID-19 and long COVID at their previous institutions. A selection:

  1. Strategic inhibition of CHRM autoantibodies: molecular insights and therapeutic potentials in long COVIDBaig AM, Rosko S, Jaeger B, Gerlach J. Journal of Medicinal Chemistry, 2025
  2. Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocolsBaig AM, Rosko S, Jaeger B, Gerlach J, Rausch H. Inflammopharmacology, 2024
  3. SARS-CoV-2 infection as a cause of neurodegenerationBonhenry D, … Baig AM, et al. The Lancet Neurology, 2024
  4. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulersBaig AM. Journal of Medical Virology, 2021
  5. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanismsBaig AM, Khaleeq A, Ali U, Syeda H. ACS Chemical Neuroscience, 2020

Dr Baig's full publication list and citation record are on his profile.